You are here

Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Schizophrenia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients with diagnosis of schizophrenia, schizophreniform or schizoaffective disorder
(DSM-IV TR)

- Patients with BMI (body mass index) more or equal to 25 Kg/m2

- Patients or their legal representative have provided written informed consent

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients are unable to complete or to understand health questionnaires in Spanish
language

- Patients are currently enrolled on clinical trials or other investigational studies

NCT00584519
Pfizer
Completed
Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now